MT Scientia OÜ

Active Registry code 14343270 OÜ Tartu linn Registered 2 Oct 2017
Compare

MT Scientia OÜ is a OÜ based in Tartu linn, registry code 14343270, status: active. Main activity: Research and experimental development on biotechnology. Its annual report for 2025 shows revenue of €0 and 0 employees.

Revenue
0 €
Employees
0
±0 vs 2024

2025 · annual report, e-Äriregister

Position in the industry Scientific research and development · EMTAK 72

  • Revenue · 2025 0 €
    industry median 0 € · companies in the industry: 1 073

Taxes and turnover

No tax data available. EMTA publishes data for those who paid state taxes, filed a VAT return or had employees in the quarter. New and small companies may be missing.

Financials by year

2018 – 2025
Revenue, € 2025: 0 € · industry median 0 € · above 5% of the industry
05001 0001 5002018 Company: — Industry median: —20182019 Company: 360 € Industry median: 0 €20192020 Company: 1 393 € Industry median: 150 €20202021 Company: 1 490 € Industry median: 0 €20212022 Company: 0 € Industry median: 103 €20222023 Company: 0 € Industry median: 76 €20232024 Company: 0 € Industry median: 0 €20242025 Company: 0 € Industry median: 0 €202505001 0001 5002018 Company: — Industry median: —2019 Company: 360 € Industry median: 0 €20192020 Company: 1 393 € Industry median: 150 €2021 Company: 1 490 € Industry median: 0 €20212022 Company: 0 € Industry median: 103 €2023 Company: 0 € Industry median: 76 €20232024 Company: 0 € Industry median: 0 €2025 Company: 0 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: -200 € · +82.3% vs 2024 · industry median 0 € · above 29% of the industry
-1 500-1 000-50005001 0001 5002018 Company: — Industry median: —20182019 Company: -266 € Industry median: 3 €20192020 Company: 61 € Industry median: 28 €20202021 Company: 1 230 € Industry median: 1 €20212022 Company: 0 € Industry median: 0 €20222023 Company: 0 € Industry median: 0 €20232024 Company: -1 127 € Industry median: 0 €20242025 Company: -200 € Industry median: 0 €2025-1 500-1 000-50005001 0001 5002018 Company: — Industry median: —2019 Company: -266 € Industry median: 3 €20192020 Company: 61 € Industry median: 28 €2021 Company: 1 230 € Industry median: 1 €20212022 Company: 0 € Industry median: 0 €2023 Company: 0 € Industry median: 0 €20232024 Company: -1 127 € Industry median: 0 €2025 Company: -200 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2021: 82.6 % · +78.2 pp vs the year before · industry median 25.1 % · above 84% of the industry
0204060801002018 Company: — Industry median: —20182019 Company: — Industry median: 12.7 %20192020 Company: 4.4 % Industry median: 23.8 %20202021 Company: 82.6 % Industry median: 25.1 %20212022 Company: — Industry median: 17.7 %20222023 Company: — Industry median: 16.8 %20232024 Company: — Industry median: 15.8 %20242025 Company: — Industry median: 13.5 %20250204060801002018 Company: — Industry median: —2019 Company: — Industry median: 12.7 %20192020 Company: 4.4 % Industry median: 23.8 %2021 Company: 82.6 % Industry median: 25.1 %20212022 Company: — Industry median: 17.7 %2023 Company: — Industry median: 16.8 %20232024 Company: — Industry median: 15.8 %2025 Company: — Industry median: 13.5 %2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 836 € · −19.3% vs 2024
05001 0001 5002 0002 5002018 Company: —20182019 Company: 397 €20192020 Company: 743 €20202021 Company: 2 163 €20212022 Company: 2 163 €20222023 Company: 2 163 €20232024 Company: 1 036 €20242025 Company: 836 €202505001 0001 5002 0002 5002018 Company: —2019 Company: 397 €20192020 Company: 743 €2021 Company: 2 163 €20212022 Company: 2 163 €2023 Company: 2 163 €20232024 Company: 1 036 €2025 Company: 836 €2025
Equity, € 2025: 835 € · −19.3% vs 2024
05001 0001 5002 0002 5002018 Company: —20182019 Company: 221 €20192020 Company: 582 €20202021 Company: 2 162 €20212022 Company: 2 162 €20222023 Company: 2 162 €20232024 Company: 1 035 €20242025 Company: 835 €202505001 0001 5002 0002 5002018 Company: —2019 Company: 221 €20192020 Company: 582 €2021 Company: 2 162 €20212022 Company: 2 162 €2023 Company: 2 162 €20232024 Company: 1 035 €2025 Company: 835 €2025
Employees 2025: 0 · industry median 1 · above 2% of the industry
0.00.51.01.52.02018 Company: 1 Industry median: 120182019 Company: 1 Industry median: 120192020 Company: 1 Industry median: 120202021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 220222023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 120242025 Company: 0 Industry median: 120250.00.51.01.52.02018 Company: 1 Industry median: 12019 Company: 1 Industry median: 120192020 Company: 1 Industry median: 12021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 22023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 12025 Company: 0 Industry median: 12025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 0 -200 0 836 835 0
2024 0 -1 127 0 1 036 1 035 0
2023 0 0 0 2 163 2 162 0
2022 0 0 0 2 163 2 162 0
2021 1 490 1 230 0 2 163 2 162 0
2020 1 393 61 781 743 582 1
2019 360 -266 156 397 221 1
2018 — — — — — 1

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Return on equity (ROE)
-24.0 %
Net profit / equity
Return on assets (ROA)
-23.9 %
Net profit / assets
Equity ratio
99.9 %
Equity / assets
Debt ratio
0.1 %
Liabilities / assets
Current ratio
836.00
Current assets / current liabilities

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 29 Jun 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 27 Jun 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 27 Jun 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 19 Jun 2023 Company’s own e-Äriregister
2021 1 Jan 2021 – 31 Dec 2021 29 Jun 2022 Company’s own e-Äriregister
2020 1 Jan 2020 – 31 Dec 2020 4 May 2021 Company’s own e-Äriregister
2019 1 Jan 2019 – 31 Dec 2019 31 May 2020 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

No beneficial owners listed.

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 72111Research and experimental development on biotechnology Main
Rulings
Number, date Title Deadline State Document
Ä 50066538 / 7
1 Sep 2023
Amendment entry In force
1 Sep 2023
PDF
Ä 50066538 / M2
3 Sep 2019
Public service of a ruling in Ametlikud Teadaanded In force
3 Sep 2019
PDF
Ä 50066538 / 6
29 Jul 2019
Entry refused: deficiencies not eliminated In force
7 Oct 2019
PDF
Ä 50066538 / M1
25 Jun 2019
Ruling to eliminate deficiencies 25 Jul 2019 In force
25 Jun 2019
PDF
Ä 50066538 / 5
21 Jun 2019
Amendment under Commercial Code § 525 (2) In force
21 Jun 2019
PDF
Ä 50066538 / 4
20 Jan 2018
Amendment entry In force
20 Jan 2018
PDF
Ä 50066538 / 3
19 Dec 2017
Amendment entry In force
19 Dec 2017
PDF
Ä 50066538 / 2
14 Dec 2017
Amendment entry In force
14 Dec 2017
PDF
Ä 50066538
2 Oct 2017
First entry In force
2 Oct 2017
PDF

Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data